American Century Companies’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TBPH
MAP
WAM
NM
ICM
American Century Companies's TBPH Position: Q2 2026 in Review
American Century Companies reduced its Theravance Biopharma (TBPH) stake by 13% in Q2 2026, selling an estimated $256K and leaving 102,282 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2249.
American Century Companies first reported a position in TBPH in Q1 2017 and has held it in 18 quarters since. The position peaked at $1.95M in Q4 2025. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.
- American Century Companies held 102,282 shares of Theravance Biopharma worth $1.74M as of Q2 2026.
- American Century Companies sold 15,456 Theravance Biopharma shares in Q2 2026, an estimated $256K.
- Theravance Biopharma made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2249 holding.
- American Century Companies first reported a position in Theravance Biopharma in Q1 2017 and has held it in 18 quarters since.
- American Century Companies's Theravance Biopharma position peaked at $1.95M in Q4 2025.
- 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.